{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:54:35Z","timestamp":1788267275883,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.10.085","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T01:36:10Z","timestamp":1509932170000},"page":"652-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of diphenhydramine in talc induced type 2 diabetes mellitus in Wistar rats"],"prefix":"10.1016","volume":"97","author":[{"given":"Muhammad","family":"Afzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqaiyah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Shahid","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin A.","family":"Zamzami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad A.","family":"Al-Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.10.085_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biopha.2017.08.070","article-title":"Resveratrol and diabetes: a critical review of clinical studies","volume":"5","author":"\u00d6zt\u00fcrk","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.10.085_bib0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopha.2017.02.027","article-title":"Neuroprotective effects of octreotide on diabetic neuropathy in rats","volume":"89","author":"Solmaz","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.biopha.2017.10.085_bib0015","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1167\/iovs.16-21402","article-title":"Therapeutic effects of a novel agonist of peroxisome proliferator-activated receptor alpha for the treatment of diabetic retinopathy","volume":"58","author":"Deng","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2017.10.085_bib0020","first-page":"5031","article-title":"Role of angiopoietins and tie-2 in diabetic retinopathy","volume":"9","author":"Khalaf","year":"2017","journal-title":"Electron Phys."},{"key":"10.1016\/j.biopha.2017.10.085_bib0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biopha.2017.07.095","article-title":"The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes","volume":"94","author":"Jaikumkao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.10.085_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2017.06.014","article-title":"High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes","author":"Di Pino","year":"2017","journal-title":"Nutr. Metab. Cardiovasc."},{"key":"10.1016\/j.biopha.2017.10.085_bib0035","first-page":"213","article-title":"Podiatric risk screening in patients with type 2 diabetes in Antananarivo","volume":"7","author":"Raharinavalona","year":"2017","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.biopha.2017.10.085_bib0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrendo.2016.105","article-title":"Diabetes mellitus statistics on prevalence and mortality: facts and fallacies","volume":"12","author":"Zimmet","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2017.10.085_bib0045","series-title":"General Notices (1) Apply to All Monographs and Other Texts","author":"European pharmacopoeia 9.0","year":"2016"},{"key":"10.1016\/j.biopha.2017.10.085_bib0050","series-title":"Principles of Biochemistry","first-page":"525","author":"Nelson","year":"2012"},{"issue":"15","key":"10.1016\/j.biopha.2017.10.085_bib0055","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1021\/jf505425d","article-title":"Dietary phenolic compounds selectively inhibit the individual subunits of maltase-glucoamylase and sucrase-isomaltase with the potential of modulating glucose release","volume":"63","author":"Simsek","year":"2015","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.085_bib0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejca.2013.09.020","article-title":"Talc used in anticancer drugs is promoter for diabetes in hepatocellular carcinoma induced rats","volume":"50","author":"Singh","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2017.10.085_bib0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MJT.0b013e3181ff7c79","article-title":"Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations","volume":"20","author":"Kar","year":"2013","journal-title":"Am. J. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.085_bib0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1345\/aph.1Q110","article-title":"Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population","volume":"45","author":"Amend","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2017.10.085_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-511X-9-4","article-title":"The mechanism of dietary cholesterol effects onlipids metabolism in rats","volume":"9","author":"Wang","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2017.10.085_bib0080","series-title":"The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"key":"10.1016\/j.biopha.2017.10.085_bib0085","first-page":"1","article-title":"Pharmacological evaluation of fractioned extract of Callistemon lanceolatus for antidiabetic and hypolipidemic activities in diabetic rats","volume":"1","author":"Kumar","year":"2011","journal-title":"J. Pharm. Allied Health Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.085_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/jbcpp-2015-0037","article-title":"Protective effect of dietary fenugreek (Trigonellafoenum- graecum) seeds and garlic (Allium sativum) on induced oxidation of low-density lipoprotein in rats","volume":"27","author":"Mukthamba","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.085_bib0095","first-page":"259","article-title":"Hypolipidemic effect of Aeglemarmelosleaf extract in streptozotocin induced diabetic male albino rats","volume":"2","author":"Devi","year":"2010","journal-title":"Int. J. PharmTech Res."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.085_bib0100","first-page":"2473","article-title":"pirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study","volume":"21","author":"Szulinska","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2017.10.085_bib0105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3923\/pjbs.2010.723.730","article-title":"Lipid peroxidation alterations in type 2 diabetic patients","volume":"13","author":"Marjani","year":"2010","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2017.10.085_bib0110","unstructured":"The Merck Index, 2013. (Merck Research Laboratories Division of Merck and Co., Inc., Whitehouse Station. 15th Edn NJ, 607)."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217324587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217324587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:18:10Z","timestamp":1780337890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217324587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"alternative-id":["S0753332217324587"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.085","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of diphenhydramine in talc induced type 2 diabetes mellitus in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}